T

Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM

Watchlist Manager
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Watchlist
Price: 3 785.9 INR 1.75% Market Closed
Market Cap: 1.3T INR

Intrinsic Value

The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 2 396.78 INR. Compared to the current market price of 3 785.9 INR, Torrent Pharmaceuticals Ltd is Overvalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TORNTPHARM Intrinsic Value
2 396.78 INR
Overvaluation 37%
Intrinsic Value
Price
T
Worst Case
Base Case
Best Case

Valuation History
Torrent Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about TORNTPHARM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TORNTPHARM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Torrent Pharmaceuticals Ltd.

Explain Valuation
Compare TORNTPHARM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TORNTPHARM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Torrent Pharmaceuticals Ltd

Current Assets 61.7B
Cash & Short-Term Investments 10.3B
Receivables 21.9B
Other Current Assets 29.5B
Non-Current Assets 93.4B
Long-Term Investments 710m
PP&E 39.5B
Intangibles 43.8B
Other Non-Current Assets 9.4B
Current Liabilities 44.4B
Accounts Payable 16.8B
Other Current Liabilities 27.6B
Non-Current Liabilities 26.3B
Long-Term Debt 12.4B
Other Non-Current Liabilities 13.9B
Efficiency

Free Cash Flow Analysis
Torrent Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Torrent Pharmaceuticals Ltd

Revenue
122.5B INR
Cost of Revenue
-29.8B INR
Gross Profit
92.7B INR
Operating Expenses
-60.8B INR
Operating Income
31.9B INR
Other Expenses
-10.5B INR
Net Income
21.4B INR
Fundamental Scores

TORNTPHARM Profitability Score
Profitability Due Diligence

Torrent Pharmaceuticals Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROE
Exceptional ROE
Exceptional Gross Margin
ROE is Increasing
64/100
Profitability
Score

Torrent Pharmaceuticals Ltd's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

TORNTPHARM Solvency Score
Solvency Due Diligence

Torrent Pharmaceuticals Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
70/100
Solvency
Score

Torrent Pharmaceuticals Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TORNTPHARM Price Targets Summary
Torrent Pharmaceuticals Ltd

Wall Street analysts forecast TORNTPHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TORNTPHARM is 4 073.01 INR with a low forecast of 3 565.3 INR and a high forecast of 4 599 INR.

Lowest
Price Target
3 565.3 INR
6% Downside
Average
Price Target
4 073.01 INR
8% Upside
Highest
Price Target
4 599 INR
21% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for TORNTPHARM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one TORNTPHARM stock?

The intrinsic value of one TORNTPHARM stock under the Base Case scenario is 2 396.78 INR.

Is TORNTPHARM stock undervalued or overvalued?

Compared to the current market price of 3 785.9 INR, Torrent Pharmaceuticals Ltd is Overvalued by 37%.

Back to Top